JPWO2004007511A1 - Mangosteen extract - Google Patents

Mangosteen extract Download PDF

Info

Publication number
JPWO2004007511A1
JPWO2004007511A1 JP2004521128A JP2004521128A JPWO2004007511A1 JP WO2004007511 A1 JPWO2004007511 A1 JP WO2004007511A1 JP 2004521128 A JP2004521128 A JP 2004521128A JP 2004521128 A JP2004521128 A JP 2004521128A JP WO2004007511 A1 JPWO2004007511 A1 JP WO2004007511A1
Authority
JP
Japan
Prior art keywords
extract
mangosteen
water
acid
fruit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004521128A
Other languages
Japanese (ja)
Inventor
榮信 加藤
榮信 加藤
真也 細田
真也 細田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hosoda SHC Inc
Original Assignee
Hosoda SHC Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hosoda SHC Inc filed Critical Hosoda SHC Inc
Publication of JPWO2004007511A1 publication Critical patent/JPWO2004007511A1/en
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/38Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00Anti-perspirants or body deodorants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/78Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Birds (AREA)
  • Biochemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Oncology (AREA)
  • Medical Informatics (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

未熟なマンゴスチン果実から特別な操作を施すことなく、赤い着色がない、種々の作用を有する抽出物及びその製造方法を提供する。未熟なマンゴスチン果実を水及び/又は有機溶媒で抽出して抽出物を得る。The present invention provides an extract having various effects and a method for producing the same, which is not red-colored without special operation from immature mangosteen fruit. An immature mangosteen fruit is extracted with water and / or an organic solvent to obtain an extract.

Description

本発明は、マンゴスチン抽出物及びその製造方法に関する。  The present invention relates to a mangosteen extract and a method for producing the same.

マンゴスチン抽出物は、下記のような有用な生理作用(薬効)を有するとされている。
▲1▼食品中の脂質の酸化を抑制し生物を酸化的障害から保護する抗酸化作用(特開平8−225783号等)、
▲2▼プロスタグランジン類の生合成を抑制するシクロオキシゲナーゼ阻害作用(特開2002−47180号等)、
▲3▼ケミカルメディエーターの受容体への結合を阻害する抗アレルギー作用(特開平10−72357号等)
▲4▼日焼けによる色素沈着を抑制する美白作用(特開平4−244004号等)、
▲5▼男性型脱毛の進行を抑えるテストステロン5α−レダクターゼ阻害作用(特開平5−17365号等)
▲6▼有害微生物の増殖による異臭・悪臭に対し優れた抗菌・消臭作用(特開平7−147951・250658号、特開平8−231396号、特開平9−95453・110688号、及び特開平2001−247469号等)。
しかし、いずれも明らかに熟したマンゴスチンの果皮と判断されるものを使用しており、未熟な果実の果皮を使用するとの言及は見当たらない。
熟したマンゴスチンの果皮は褐色をしており、メタノール、エタノール、アセトンなどの水溶性有機溶媒(極性溶媒)又はそれらの水溶液で抽出して得られるマンゴスチン抽出物は赤く着色しているため、色の影響を受けるものには利用できないという問題点があった。
このため、前記特開平9−95453号に赤い色及び吸湿性物質が除去されたマンゴスチンエキスの抗菌性組成物が記載されている。
The mangosteen extract is said to have the following useful physiological effects (medicinal effects).
(1) Antioxidant action that inhibits lipid oxidation in food and protects organisms from oxidative damage (Japanese Patent Laid-Open No. 8-225783, etc.)
(2) Cyclooxygenase inhibitory action that suppresses the biosynthesis of prostaglandins (Japanese Patent Application Laid-Open No. 2002-47180, etc.),
(3) Antiallergic action that inhibits the binding of chemical mediators to receptors (JP-A-10-72357, etc.)
(4) Whitening action to suppress pigmentation due to sunburn (JP-A-4-244004, etc.)
(5) Testosterone 5α-reductase inhibitory action to suppress the progression of male pattern hair loss (Japanese Patent Laid-Open No. 5-17365, etc.)
(6) Excellent antibacterial and deodorant action against off-flavors and bad odors caused by the growth of harmful microorganisms (Japanese Patent Laid-Open Nos. 7-147951, 250658, 8-231396, 9-95453, 110688, and 2001) -247469 etc.).
However, all use what is clearly judged to be ripe mangosteen peel, and there is no mention of using unripe fruit peel.
The ripe mangosteen peel is brown, and the mangosteen extract obtained by extraction with a water-soluble organic solvent (polar solvent) such as methanol, ethanol, acetone, or their aqueous solution is colored red. There was a problem that it could not be used for those affected.
For this reason, an antibacterial composition of mangosteen extract from which red color and hygroscopic substances are removed is described in the above-mentioned JP-A-9-95453.

本発明の目的は、上記にかんがみて、特別な操作を施すことなく、赤い着色がない、種々の作用を有するマンゴスチン抽出物及びその製造方法を提供することを目的とする。
本発明者らは、熟していないマンゴスチン果実は赤色色素不含の緑色をしており、果実に傷をつけると淡黄色の乳濁液が浸出(熟したマンゴスチン果実では浸出しない。)してくることを見出し、この浸出液の利用を考えて本発明を完成するに至った。
すなわち、本発明の構成は、熟していない(未熟)マンゴスチン果実を、水及び/又は有機溶媒で抽出してなるマンゴスチン抽出物にある。
上記構成において、褐変防止剤と共に抽出されたものとすることが望ましい。マンゴスチン抽出物の保存時における褐変を防止できる。
マンゴスチン抽出物の態様は、水溶性及び非水溶性の双方がある。
そして、上記各構成のマンゴスチン抽出物を製造する方法としては、下記のような方法がある。
一つは、未熟なマンゴスチン果実を、褐変防止剤の存在下又は非存在下、水及び/又は有機溶媒に浸潰し、浸潰液をろ過後、ろ過液から溶媒を分離除去することにより製造することを特徴とするものである。
他の一つは、未熟なマンゴスチン果実を、褐変防止剤の存在下又は非存在下、水及び/又は有機溶媒に浸潰し、浸潰液をろ過後、該ろ過液の溶媒を除去する濃縮工程で、析出する黄色の非水溶性マンゴスチン抽出物を得、更に、溶媒を除去した液から溶媒を留去することにより水溶性マンゴスチン抽出物を、それぞれ得ることを特徴とするものである。
更に、他の一つは、未熟なマンゴスチン果実を、褐変防止剤の存在下又は非存在下、水及び/又は有機溶媒に浸潰し、加温処理により析出する黄色物質を分取して非水溶性マンゴスチン抽出物を得、他方、ろ過液から溶媒を留去することにより水溶性マンゴスチン抽出物を、それぞれ得ることを特徴とするものである。
本発明によると、未熟なマンゴスチン果実から得られるマンゴスチン抽出物は、熟したマンゴスチンに比べて赤色がないので、色物に限定されることなく無(白)色ないし淡色の製品に対しても着色の心配がなくなり、商品価値を下げることがなく、利用範囲も広く、食品、化粧品、衣類、衛生品等、種々の分野への利用が可能となる。未熟マンゴスチン果実から得られるマンゴスチン抽出物は、熟したマンゴスチンから得られるものよりもポリフェノール含量が多く、抗酸化作用が高い。
In view of the above, an object of the present invention is to provide a mangosteen extract having various effects and a method for producing the same without any special operation and without red coloring.
The present inventors have found that unripe mangosteen fruit has a red pigment-free green color, and when the fruit is damaged, a pale yellow emulsion is leached (not leached in ripe mangosteen fruit). As a result, the present invention was completed in consideration of the use of the leachate.
That is, the structure of this invention exists in the mangosteen extract formed by extracting the unripe (unripe) mangosteen fruit with water and / or an organic solvent.
In the said structure, it is desirable to be extracted with the browning prevention agent. Browning during storage of the mangosteen extract can be prevented.
Mangosteen extract embodiments are both water-soluble and water-insoluble.
And there exist the following methods as a method of manufacturing the mangosteen extract of each said structure.
One is to produce unripe mangosteen fruit by immersing it in water and / or an organic solvent in the presence or absence of an anti-browning agent, filtering the lysate, and separating and removing the solvent from the filtrate. It is characterized by this.
The other is a concentration step of immersing immature mangosteen fruit in water and / or an organic solvent in the presence or absence of an anti-browning agent, filtering the lysate and then removing the solvent of the filtrate. Thus, a yellow water-insoluble mangosteen extract that precipitates is obtained, and further, a water-soluble mangosteen extract is obtained by distilling off the solvent from the liquid from which the solvent has been removed.
Furthermore, the other is that the immature mangosteen fruit is soaked in water and / or an organic solvent in the presence or absence of a browning inhibitor, and the yellow substance precipitated by heating treatment is separated to remove water. On the other hand, a water-soluble mangosteen extract is obtained by distilling off the solvent from the filtrate, respectively.
According to the present invention, the mangosteen extract obtained from an immature mangosteen fruit has no red color compared to the ripe mangosteen, so that it is not limited to a colored product and is colored even for a non-white or light product. The product value is not lowered, the range of use is wide, and it can be used in various fields such as food, cosmetics, clothing, and hygiene products. Mangosteen extract obtained from immature mangosteen fruit has a higher polyphenol content and higher antioxidant effect than those obtained from ripe mangosteen.

図1は、本発明の製造方法の一例を示す工程図である。
図2の(A)、(B)は、それぞれ未熟なマンゴスチン及び熟したマンゴスチンより抽出した抽出物の高速液体クロマトグラフィーの分析結果を示すクロマトグラムである。
FIG. 1 is a process diagram showing an example of the production method of the present invention.
2A and 2B are chromatograms showing the results of high-performance liquid chromatography analysis of extracts extracted from immature mangosteen and ripe mangosteen, respectively.

以下の説明で、配合量・配合比は、特に断らない限り、質量基準とする。
本発明のマンゴスチン抽出物は、熟していない(未熟)のマンゴスチン果実を、必要により褐変防止剤を存在させて、水及び/又は有機溶媒で抽出してなる、マンゴスチン抽出物にある。
ここで、「抽出物(extracted material)」とは、「抽剤(溶剤:solvent)」中に、「抽料(原料:raw material)」に溶解状態で移動「浸出(leach)又は溶出(elute,dissolve)」してきた物質(本来の抽出物)ばかりでなく、非溶解状態で移動してきた物質も含む。
マンゴスチンとは、学名「Garcinia mangostana L.」と称される、タイを原産国とするオトギリソウ科の一群の植物で、東南アジア地域に広く栽培されているものをいう。なお、マンゴスチンの果肉は甘味と酸味が適度に調和して上品な味で好まれ、また、果皮はコレラや赤痢の治療、下痢止め、更に中枢神経系鎮静剤や血圧上昇剤として利用されている。
「マンゴスチンの未熟な果実」とは、熟していないマンゴスチン果実で緑色又はわずかに褐色を帯びており、傷をつけると黄色を帯びた乳白色の粘性のある液が浸出し、ガラス板をあてると接した面に黄色い液が付着するものをいう。
「果実」とは、果実全体又は果皮のことを意味し、加熱処理後小さくカットして乾燥した乾燥物及び未乾燥物(生)の何れの状態のものも含む。なお、乾燥物、未乾燥物ともに、通常、粉砕機で中間粉粒(3〜20mm)の大きさに粉砕するか、クラッシャーで押し潰すか(厚さ3mm前後)、又は、スライサーで薄く(例えば、1mm前後)スライスして、抽料(原料)とする。
抽剤とする「水及び有機溶媒(極性溶媒)」とは、水及びメタノール、エタノール、1−プロパノール、2−プロパノン(アセトン)などの水と自由に混和又は、ブタノール、酢酸エチル等の水に対して易溶な有機溶媒を指し、単一で又は混合して用いる。当然のことながら、毒性の低いものを選択する。
抽剤(溶剤:溶媒)その使用量は、マンゴスチン果実1部に対し1〜50部、望ましくは2〜30部とする。過少では抽出物の収量が低くなり、過多では溶剤除去・分離に時間がかかるので好ましくない。
そして、本発明の方法で得たマンゴスチン抽出物には、適宜、褐変防止剤を添加する。この添加時期は、抽出処理時に又は抽出処理に先立ち抽剤に添加しても、抽出後(分離回収後)のマンゴスチン抽出物(抽質)に添加してもよい。マンゴスチン果実を水や有機溶剤で抽出しただけでは、褐変酵素が作用して浸出液及び抽出液が褐色を呈するので、それらを抑制(防止)するためである。
ここで「褐変防止剤」としては、下記のような有機酸、無機酸のうちから、適宜、1種又は2種以上を選択して使用可能であり、更に、醸造酢やビネガーなども使用可能である。
モノカルボン酸:エタン酸(酢酸)、乳酸(2−ヒドロキシプロパン酸)、プロピオン酸(プロパン酸)等
ポリカルボン酸:アジピン酸(ヘキサン二酸)、酒石酸(2,3−ジヒドロキシブタン二酸)、コハク酸(ブタン二酸)、フマル酸(trans−ブテン二酸)、リンゴ酸(2−ヒドロキシブタン二酸)、クエン酸(2−ヒドロキシプロパン−1,2,3−トリカルボン酸)等
糖アルコール誘導体:アスコルビン酸(ビタミンC)、エリソルビン酸(イソアスコルビン酸;Erythorbic acid)、グルコン酸、グルコノラクトン(グルコノ酸ラクトン)、フィチン酸(イノシトールヘキサリン酸)等
アミノ酸:アスパラギン酸、グルタミン酸等
無機酸:塩酸、硫酸、りん酸、りん酸−ナトリウム
褐変防止剤の添加量は、添加濃度が0.001〜5w/v%、好ましくは0.01〜2w/v%となる量とする。添加濃度が、低過ぎては褐変防止効果を得難く、高すぎてはマンゴスチン抽出物中に褐変防止剤の残留量が多くなって好ましくない。
マンゴスチン抽出物の着色を抑制(防止)するとは、果実から抽出(浸出)する水溶性抽出物又は非水溶性抽出物(黄色液)の変色(褐変)を抑制(防止)することである。このためには果実中の酵素の働きを抑えるか、又は、酵素が作用しない失活状態とする必要がある。抽出に用いる抽剤を構成する溶剤成分において有機溶剤(溶媒)含量が小さいときに褐変防止剤を加えることが、褐変防止効果が大きくなって望ましい。
本発明での抽出物は、赤色色素を含まないものであり、「THE MERCK INDEX(TWELFTH EDITION)5785」(978頁)に記載されているマンゴスチンが主成分である。
本発明のマンゴスチン抽出物は、次のようにして製造することができる。以下に製造方法の例を示す(図1参照)。
(1)抽料調製工程
未熟なマンゴスチン果実を破砕、スライス又は押し潰す等して抽料を調製する。このときの破砕物、スライス物又は、押し潰し物等の大きさは、下記の如くとする。
破砕物:1〜50mm、望ましくは2〜30mm
スライス物:厚さ0.2〜2mm、望ましくは0.3〜1mm(大きさ10〜50mm)
押潰し物:厚さ0.5〜5mm、望ましくは1〜3mm(大きさ20〜70mm)
とする。小さくしすぎると、果実の破砕等の際に、マンゴスチン中の抽質(有効成分)が抽出操作前にスライス機や破砕機中に漏出し易い。他方、大きくしすぎると、抽料の比表面積が大きくなって、抽出効率が低下して、抽出に時間がかかる。
(2)抽出処理工程
抽料を抽剤と混合・接触させる。このとき、抽料に対する抽剤(褐変防止剤を含む場合がある。)の混合質量比(抽料/抽剤)=1/1〜1/50、望ましくは1/2〜1/30、更に望ましくは1/3〜1/20とする。抽剤が過少では、抽出効率が低下し、抽剤が過多では、無駄であるととともに、抽剤の分離回収の作業性が低下する。
そして、抽出条件は、抽出態様及び粉砕物等の形態により異なるが、例えば、浸潰(回分)の場合、下記の如くとする。
粉砕物:室温〜沸騰温度×数時間〜数日間、望ましくは、50〜90℃×2〜24h
スライス物、押し潰し物:室温〜沸騰温度×数分〜数時間、望ましくは5〜120min
なお、抽出処理の態様は、回分式・半連続式・連続式いずれの操作法でもよく、抽料/抽剤の接触態様も、固定層式(浸潰)、移動層式、分散接触式のいずれでもよい。
(3)固液分離工程
溶液(抽出液)と残滓(抽残物)とを固液分離する。固液分離の方法としては、沈降分離、遠心分離等、特に限定されないが、通常、ろ過(遠心ろ過、圧搾ろ過等)による。
(4)抽出物回収工程
抽出液から溶剤を分離除去して抽質を回収する。溶剤の分離除去は、蒸発晶析により又は冷却晶析させた後、ろ過して行う。
ここで、抽剤として、有機溶剤又は有機溶剤/水混合溶剤を用いた場合は、水溶性抽出物とともに非水溶性抽出物(黄色の非水溶性物質)を得ることができる。
そして、抽出物は、通常、乾燥処理を行って、本発明のマンゴスチン抽出物とする。なお、乾燥方法は、凍結乾燥、常温乾燥、加熱乾燥、真空乾燥、噴霧乾燥等任意である。
また、必要ならば、マンゴスチン抽出物をシリカゲル、アルミナ、アルキルシリル化シリカゲル(逆相クロマト用充填剤、例えばODSなど)、ポーラスポリマー(例えば、スチレン系、ヒドロキシメタクリレート系、レジン系)、架橋デキストランなどのゲル濾過剤(例えば、Shephadex、Bio Gel)などを用いる公知の方法によりα−マンゴスチン、β−マンゴスチン、γ−マンゴスチン、エピカテキン、プロシアニジンなどの単一物に分離精製することができる。
なお、上記抽出方法は、超臨界抽出によってもよい。
上記で得た非水溶性マンゴスチン抽出物及びそれを含むマンゴスチン抽出物はそのまま単独では水に溶けないので、以下に示すような製剤法▲1▼〜▲3▼により、水溶性又は水分散性の製剤とすることが望ましい。
▲1▼水と混合したとき均一に溶解又は分散させるためにα−、β−及びγ−シクロデキストリン、分岐(又は分枝)シクロデキストリンなどの包接剤(inclusion agent)を加えて混合し、アルコール及び水を加えて練合・乾燥或いは溶解・乾燥(噴霧乾燥や凍結乾燥を含む)などの常法により処理した後、粉砕・篩過などの操作を行って整粒(造粒)する。
この製剤に際して、必要に応じてデキストリン、オリゴ糖などの水溶性糖類、酢酸、アスコルビン酸などの有機酸及びその塩、グリシン、グルタミン酸ナトリウムなどのアミノ酸、りん酸カリウム、塩化ナトリウムなどの無機塩などの賦形剤を添加することもできる。
包接剤の非水溶性マンゴスチン抽出物1部に対する混合比は、包摂剤/抽出物=1/2〜1/30、望ましくは1/3〜1/20とする。
▲2▼水と混合したとき均一に溶解又は分散させるためにグリセリン脂肪酸エステル、ショ糖脂肪酸エステル、ソルビタン脂肪酸エステル、プロピレングリコール脂肪酸エステル、レシチンなどの界面活性剤の少なくとも一種に直接混合溶融又はアルコールなどの前記有機溶媒に一旦溶解後、溶媒を留去することによりペースト状のマンゴスチン抽出物製剤を得ることができる。必要ならばデキストリン、オリゴ糖などの水溶性糖類、クエン酸、アスコルビン酸などの有機酸及びその塩、グリシン、グルタミン酸ナトリウムなどのアミノ酸、りん酸カリウム、塩化ナトリウムなどの無機塩、エタノール、プロピレングルコール、油脂などの賦形剤を添加することもできる。界面活性剤の使用量は非水溶性マンゴスチン抽出物1部に対し、0.5〜20部、望ましくは1〜10部の範囲である。
▲3▼マンゴスチン抽出物に、賦形剤として水、エタノールや2−プロパノールなどの1価アルコール、プロピレングルコール、ジプロピレングリコール、グリセリン、ソルビトールなどの多価アルコールなど、乳化剤として前記界面活性剤など、pH調整剤として酢酸、アジピン酸、フマル酸、乳酸、リンゴ酸、クエン酸、酒石酸、グルコン酸、アスコルビン酸、フィチン酸などの有機酸及びその塩、塩酸、炭酸、リン酸、ピロリン酸、ポリリン酸などの無機酸及びその塩、グリシン、アラニン、リジン、グルタミン酸、ヒスチジン、アルギニン、ベタインなどのアミノ酸及びその塩、水酸化ナトリウムなどの塩基などを適宜組み合わせて液状又はペースト状のマンゴスチン抽出物製剤を得ることができる。さらに、酸化防止剤のトコフェロール(ビタミンE)、アスコルビン酸、パルミチン酸エステル、エリソルビン酸、アスコルビン酸ステアリン酸エステルなどを配合することもできる。
<実施例・比較例等>
以下、実施例・比較例等により本発明をさらに詳細に説明する。なお、以下の説明において、「果皮」、「果実」は、特に断らない限り、「未熟マンゴスチン」の非乾燥品を意味し、更に、「抽出物」は、「マンゴスチン抽出物」のことである。
また、「微黄褐色」及び「淡黄褐色」とは、かすか(slightly)な及び薄い(pale)黄褐色をそれぞれ意味する。
In the following description, the blending amount and blending ratio are based on mass unless otherwise specified.
The mangosteen extract of the present invention is a mangosteen extract obtained by extracting an unripe (unripe) mangosteen fruit with water and / or an organic solvent in the presence of a browning inhibitor as necessary.
Here, the term “extracted material” means that the “extracted material (solvent: solvent)” is dissolved in the “extract (raw material)” in a dissolved state, and “leach” or eluate (eluted). , Dissolve) "as well as substances that have migrated in an undissolved state.
Mangosteen refers to a group of hypericaceae plants called “Garcinia mangostana L.”, whose origin is Thailand, and is widely cultivated in the Southeast Asian region. Mangosteen pulp is preferred for its elegant taste with a moderate harmony between sweetness and sourness, and the skin is used as a treatment for cholera and dysentery, to prevent diarrhea, and as a central nervous system sedative and blood pressure increasing agent. .
`` Unripe mangosteen fruit '' is an unripe mangosteen fruit that is green or slightly brownish, and when it is scratched, a yellowish milky white viscous liquid oozes out and touches the glass plate. This means that yellow liquid adheres to the surface.
“Fruit” means the whole fruit or pericarp, and includes both dried and undried (raw) dried and raw cuts after heat treatment. Note that both dried and undried materials are usually pulverized to a size of intermediate particles (3 to 20 mm) with a pulverizer, crushed with a crusher (thickness around 3 mm), or thin with a slicer (for example, Slice 1 mm) to obtain a lottery (raw material).
“Water and organic solvent (polar solvent)” used as an extractant is freely mixed with water and water such as methanol, ethanol, 1-propanol, 2-propanone (acetone), or in water such as butanol and ethyl acetate. It refers to an organic solvent that is easily soluble, and is used alone or in combination. Of course, select one with low toxicity.
The extractant (solvent: solvent) is used in an amount of 1 to 50 parts, preferably 2 to 30 parts per 1 part of mangosteen fruit. If the amount is too small, the yield of the extract will be low.
And the browning inhibitor is added suitably to the mangosteen extract obtained by the method of the present invention. This addition time may be added to the extract during the extraction process or prior to the extraction process, or may be added to the mangosteen extract (extract) after extraction (after separation and recovery). This is because if the mangosteen fruit is simply extracted with water or an organic solvent, the browning enzyme acts and the leachate and the extract exhibit a brown color, thereby suppressing (preventing) them.
Here, as the “browning inhibitor”, one or more kinds can be appropriately selected from the following organic acids and inorganic acids, and brewed vinegar or vinegar can also be used. It is.
Monocarboxylic acid: ethanoic acid (acetic acid), lactic acid (2-hydroxypropanoic acid), propionic acid (propanoic acid), etc. Polycarboxylic acid: adipic acid (hexanedioic acid), tartaric acid (2,3-dihydroxybutanedioic acid), Sugar alcohol derivatives such as succinic acid (butanedioic acid), fumaric acid (trans-butenedioic acid), malic acid (2-hydroxybutanedioic acid), citric acid (2-hydroxypropane-1,2,3-tricarboxylic acid) : Ascorbic acid (vitamin C), erythorbic acid (isoascorbic acid; gluconic acid, gluconolactone (gluconoic acid lactone), phytic acid (inositol hexaphosphoric acid), etc. Amino acids: Aspartic acid, glutamic acid, etc. Inorganic acids: Hydrochloric acid, sulfuric acid, phosphoric acid, phosphoric acid-sodium Pressurizing concentration 0.001~5w / v%, preferably an amount corresponding to 0.01~2w / v%. If the addition concentration is too low, it is difficult to obtain the effect of preventing browning, and if it is too high, the residual amount of the browning inhibitor is undesirably increased in the mangosteen extract.
Suppressing (preventing) coloring of the mangosteen extract is suppressing (preventing) discoloration (browning) of the water-soluble extract or non-water-soluble extract (yellow liquid) extracted (leached) from the fruit. For this purpose, it is necessary to suppress the action of the enzyme in the fruit or to make it inactivated so that the enzyme does not act. It is desirable to add an anti-browning agent when the organic solvent (solvent) content is small in the solvent component constituting the extractant used for extraction because the effect of preventing browning is increased.
The extract in the present invention does not contain a red pigment, and is mainly composed of mangosteen described in “THE MERCK INDEX (TWELFTH EDITION) 5785” (page 978).
The mangosteen extract of the present invention can be produced as follows. The example of a manufacturing method is shown below (refer FIG. 1).
(1) Extract preparation step The extract is prepared by crushing, slicing or crushing immature mangosteen fruit. The size of the crushed material, sliced material, or crushed material is as follows.
Crushed material: 1 to 50 mm, desirably 2 to 30 mm
Sliced material: thickness 0.2-2 mm, desirably 0.3-1 mm (size 10-50 mm)
Crushed material: thickness 0.5 to 5 mm, desirably 1 to 3 mm (size 20 to 70 mm)
And If it is too small, the extract (active ingredient) in mangosteen is likely to leak into the slicing machine or crusher before the extraction operation when crushing the fruit. On the other hand, if it is too large, the specific surface area of the extract will be increased, the extraction efficiency will be reduced, and extraction will take time.
(2) Extraction process step The extract is mixed and brought into contact with the extract. At this time, the mixing mass ratio of the extractant (which may include a browning inhibitor) to the extract (extractant / extractant) = 1/1 to 1/50, preferably 1/2 to 1/30, Desirably, 1/3 to 1/20. If the amount of the extract is too small, the extraction efficiency is reduced. If the amount of the extract is excessive, it is useless and the workability of separating and recovering the extract is reduced.
And although extraction conditions differ with forms, such as an extraction aspect and a pulverized material, it is as follows in the case of immersion (batch).
Pulverized product: room temperature to boiling temperature x several hours to several days, preferably 50 to 90 ° C x 2 to 24 hours
Sliced product, crushed product: room temperature to boiling temperature x several minutes to several hours, preferably 5 to 120 min
The mode of extraction treatment may be any of batch, semi-continuous and continuous operation methods, and the extraction / extraction contact mode may be fixed bed type (soaking), moving bed type, or distributed contact type. Either is acceptable.
(3) Solid-liquid separation step The solution (extract) and residue (extracted residue) are subjected to solid-liquid separation. The method of solid-liquid separation is not particularly limited, such as sedimentation separation, centrifugation, and the like, but usually by filtration (centrifugal filtration, squeeze filtration, etc.).
(4) Extract recovery process The extract is recovered by separating and removing the solvent from the extract. The solvent is separated and removed by evaporative crystallization or cooling crystallization, followed by filtration.
Here, when an organic solvent or an organic solvent / water mixed solvent is used as the extractant, a water-insoluble extract (yellow water-insoluble substance) can be obtained together with the water-soluble extract.
The extract is usually subjected to a drying treatment to obtain the mangosteen extract of the present invention. The drying method is arbitrary such as freeze drying, room temperature drying, heat drying, vacuum drying, spray drying and the like.
In addition, if necessary, the mangosteen extract can be converted into silica gel, alumina, alkylsilylated silica gel (reverse phase chromatographic filler, such as ODS), porous polymer (for example, styrene, hydroxy methacrylate, resin), crosslinked dextran, etc. Can be separated and purified into a single substance such as α-mangostin, β-mangostin, γ-mangostin, epicatechin, procyanidin, etc. by a known method using a gel filtration agent (eg, Shephadex, Bio Gel).
The extraction method may be supercritical extraction.
Since the water-insoluble mangosteen extract obtained above and the mangosteen extract containing it are not soluble in water as they are, they are dissolved in water or dispersible by the following formulation methods (1) to (3). It is desirable to prepare a formulation.
(1) Add and mix inclusion agents such as α-, β- and γ-cyclodextrins, branched (or branched) cyclodextrins to uniformly dissolve or disperse when mixed with water; Alcohol and water are added and the mixture is processed by conventional methods such as kneading, drying or dissolution / drying (including spray-drying and freeze-drying), and then pulverized and sieved to adjust the size (granulation).
In this preparation, water-soluble saccharides such as dextrin and oligosaccharide, organic acids such as acetic acid and ascorbic acid and salts thereof, amino acids such as glycine and sodium glutamate, inorganic salts such as potassium phosphate and sodium chloride, as necessary. Excipients can also be added.
The mixing ratio of the clathrate to 1 part of the water-insoluble mangosteen extract is inclusive agent / extract = 1/2 to 1/30, preferably 1/3 to 1/20.
(2) In order to dissolve or disperse uniformly when mixed with water, it is directly mixed and melted with at least one surfactant such as glycerin fatty acid ester, sucrose fatty acid ester, sorbitan fatty acid ester, propylene glycol fatty acid ester, lecithin or alcohol. Once dissolved in the organic solvent, a pasty mangosteen extract preparation can be obtained by distilling off the solvent. If necessary, water-soluble saccharides such as dextrin and oligosaccharide, organic acids such as citric acid and ascorbic acid and salts thereof, amino acids such as glycine and sodium glutamate, inorganic salts such as potassium phosphate and sodium chloride, ethanol and propylene glycol Further, excipients such as fats and oils can be added. The amount of the surfactant used is in the range of 0.5 to 20 parts, preferably 1 to 10 parts, with respect to 1 part of the water-insoluble mangosteen extract.
(3) In mangosteen extract, water, monohydric alcohols such as ethanol and 2-propanol, polyhydric alcohols such as propylene glycol, dipropylene glycol, glycerin and sorbitol, etc., surfactants as emulsifiers, etc. Acetic acid, adipic acid, fumaric acid, lactic acid, malic acid, citric acid, tartaric acid, gluconic acid, ascorbic acid, phytic acid and the like as pH adjusting agents and salts thereof, hydrochloric acid, carbonic acid, phosphoric acid, pyrophosphoric acid, polyphosphorus Liquid or pasty mangosteen extract preparations by appropriately combining inorganic acids such as acids and salts thereof, amino acids such as glycine, alanine, lysine, glutamic acid, histidine, arginine, betaine, and salts thereof, bases such as sodium hydroxide, etc. Obtainable. Furthermore, the antioxidant tocopherol (vitamin E), ascorbic acid, palmitic acid ester, erythorbic acid, ascorbic acid stearic acid ester, etc. can also be blended.
<Examples and comparative examples>
Hereinafter, the present invention will be described in more detail with reference to examples and comparative examples. In the following description, “peel” and “fruit” mean non-dried “unripe mangosteen” unless otherwise specified, and “extract” means “mangosteen extract”. .
In addition, “slightly yellowish brown” and “light yellowish brown” mean slightly yellow and pale yellowish brown, respectively.

抽料(果皮の抽剤中粉砕物;粉砕大きさ約2〜5mm)346gを抽剤(70%エタノール)1.1kg中に、70℃×5hの条件で浸潰して抽出処理後、該抽出処理液をろ紙ろ過して抽出液を得た(抽料/抽剤≒1/3)。
該抽出液(ろ過液)から溶剤を真空蒸発により分離除去して濃縮物を調製後、該濃縮物を凍結乾燥して、抽出物(微黄褐色粉末)48.2gを回収した(対抽料回収率≒14%)。
346 g of the extract (pulverized product in the extract of the peel; pulverized size of about 2 to 5 mm) was submerged in 1.1 kg of the extract (70% ethanol) under the conditions of 70 ° C. × 5 h, followed by extraction and extraction. The treated liquid was filtered with a filter paper to obtain an extract (extracted material / extractant≈1 / 3).
After the solvent was separated and removed from the extract (filtrate) by vacuum evaporation to prepare a concentrate, the concentrate was lyophilized to recover 48.2 g of the extract (slight tan powder) Recovery ≒ 14%).

抽料(果実の細片カット乾燥物;平均厚さ4mm)3kgを、抽剤(60%エタノール)30kgに60℃で一夜浸潰して抽出後、フィルタープレスろ過して抽出液を得た(抽料/抽剤≒1/10)。
当該抽出液を実施例1と同様にして減圧濃縮・凍結乾燥して、抽出物(微黄褐色粉末)810gを回収した(対抽料回収率≒27%)。
Extract 3 kg of extract (fruit cuts of dried fruit; average thickness 4 mm) in 30 kg of extract (60% ethanol) at 60 ° C. overnight, extract, and filter press filter to obtain an extract (extract Material / extractant 1/10).
The extract was concentrated under reduced pressure and freeze-dried in the same manner as in Example 1 to recover 810 g of the extract (slightly yellowish brown powder) (recovery rate of the extract = 27%).

抽料(果実のスライス物;平均厚さ0.5mm)して調製した抽料835gを、抽剤(水)4.6kgに50℃で1h浸潰して抽出処理を行なった(抽料/抽剤≒1/5.5)。
抽出処理液中に浮遊する黄褐色物質をろ布で採取(掬い捕り)し、65℃で6h乾燥して、非水溶性抽出物(黄褐色粉末)9.9gを回収した。他方、ろ過液をスプレードライして本発明の水溶性抽出物(淡褐色粉末)60.1gを回収した(対抽料回収率≒1.1%+7.1%)。
Extraction processing was performed by pulverizing 835 g of the extract (fruit slice; average thickness 0.5 mm) in 4.6 kg of extract (water) at 50 ° C. for 1 h (drawing / extraction). Agent ≒ 1 / 5.5).
A yellowish brown substance floating in the extraction treatment liquid was collected with a filter cloth (crawled) and dried at 65 ° C. for 6 hours to recover 9.9 g of a water-insoluble extract (yellowish brown powder). On the other hand, the filtrate was spray-dried to recover 60.1 g of the water-soluble extract (light brown powder) of the present invention (recovery rate of extraction material = 1.1% + 7.1%).

抽料(果実のスライス物;平均厚さ約0.7mm)911gを抽剤(水;50℃)5kgに投入して、10min煮沸して抽出処理を行なった(抽料/抽剤≒1/5)。
該抽出処理液から、実施例3と同様の操作を経て、非水溶性抽出物(黄色粉末)17.8g及び水溶性抽出物(淡黄褐色粉末)70.7gを回収した(対抽料回収率≒2.0%+7.8%)。
911 g of the extract (fruit slice; average thickness of about 0.7 mm) was added to 5 kg of the extract (water; 50 ° C.) and boiled for 10 min to perform the extraction process (extract / extract ≈1 / 5).
From the extraction treatment liquid, 17.8 g of a water-insoluble extract (yellow powder) and 70.7 g of a water-soluble extract (light tan powder) were recovered through the same operations as in Example 3 (collection of the extract). Rate ≒ 2.0% + 7.8%).

抽料(果皮の抽剤中粉砕物;粉砕大きさ約5〜20mm)528gを抽剤(40%エタノール)10kgに、室温で3day浸潰後、2枚重ねてガーゼでろ過して、ろ過液を得た(抽料/抽剤≒1/5)。
該ろ過液を減圧濃縮し、浮遊析出する黄色物質をろ布ろ過し、40℃で減圧乾燥して非水溶性抽出物(黄色粉末)12.6gを回収した。他方、ろ過液を凍結乾燥して水溶性抽出物(微褐色粉末)43.7gを回収した(対抽料回収率≒2.4%+8.3%)。
528 g of extract (pulverized skin extract in pulverized size; about 5 to 20 mm in size) is 10 kg of extractant (40% ethanol), 3 days soaked at room temperature, 2 layers are stacked, filtered through gauze, and filtered. Was obtained (extract / extract ≈ 1/5).
The filtrate was concentrated under reduced pressure, and the yellow substance that floated and precipitated was filtered through a cloth and dried under reduced pressure at 40 ° C. to recover 12.6 g of a water-insoluble extract (yellow powder). On the other hand, the filtrate was freeze-dried to recover 43.7 g of a water-soluble extract (slightly brown powder) (recovery rate of extraction material≈2.4% + 8.3%).

抽料(果皮の抽剤中粉砕物;粉砕大きさ約5〜20mm)574gを抽剤(アセトン)4.7kgを用いて5h加熱還流して抽出処理を行った(抽料/抽剤≒1/8)。
該抽出処理液を冷却後、2枚重ねガーゼでろ過した。ろ過液から溶剤を真空蒸発させ、残留する黄色懸濁液を凍結乾燥して非水溶性抽出物(黄色粉末)12.1gを回収した(対抽料回収率≒2.1%)。
Extraction processing was carried out by heating and refluxing 574 g of the extract (pulverized product in the extract of the skin; pulverized size of about 5 to 20 mm) using 4.7 kg of the extract (acetone) for 5 hours (extract / extract 1) / 8).
After cooling this extraction process liquid, it filtered with 2 sheets of pile gauze. The solvent was evaporated in vacuo from the filtrate, and the remaining yellow suspension was lyophilized to recover 12.1 g of a non-water-soluble extract (yellow powder) (recovery rate of extract = ≈2.1%).

果実(果実のスライス物;平均厚さ約0.5mm)868gを抽剤(ビネガー6%含有の10%エタノール)10kgに加え、10min煮沸して抽出処理を行なった(抽料/抽剤≒1/12)。
該抽出処理液を冷却後、浮遊する黄色物質をろ布で採取し、60℃で減圧乾燥して非水溶性抽出物(黄色粉末)14.3g回収した。また、ろ過液をスプレードライして本発明の水溶性抽出物(微黄褐色粉末)として67.5g回収した(対抽料回収率≒1.6%+7.8%)。
868 g of fruit (fruit slice; average thickness of about 0.5 mm) was added to 10 kg of extractant (10% ethanol containing 6% vinegar) and boiled for 10 min to perform extraction treatment (extract / extractant≈1 / 12).
After cooling the extraction treatment liquid, the floating yellow substance was collected with a filter cloth and dried under reduced pressure at 60 ° C. to recover 14.3 g of a non-water-soluble extract (yellow powder). Further, the filtrate was spray-dried to recover 67.5 g of the water-soluble extract of the present invention (slightly tan powder) (recovery rate of extraction material≈1.6% + 7.8%).

抽料(果実の押し潰し物;平均厚さ約2mm)642gを抽剤(0.2%クエン酸水溶液)2.3kg中で押し潰し、20min煮沸して、抽出処理を行なった(抽料/溶剤≒1/3.6)。
該抽出処理液を冷却後、実施例5と同様の各操作を行なって、ろ布採取物を減圧乾燥して非水溶性抽出物(黄色粉末)15.7g及び水溶性抽出物(微褐色粉末)79.6gを回収した(対抽料回収率≒2.4%+12.4%)。
(参照例1)
実施例1で得られた水溶性抽出物8g、分岐シクロデキストリン(日研化学;イソエリート P)72g及びデキストリン(松谷化学;パインデックス1)40gを50%エタノール400mlに溶解後、噴霧乾燥して抽出物の包接体として淡黄色粉末の抽出物製剤107gを調製した。
(参照例2)
実施例8で得られた非水溶性抽出物2gの熱エタノール溶液20mlにグリセリン脂肪酸エステル(理研ビタミン;ポエム M−100)3gを溶解して減圧濃縮後、プロピレングリコール2gを添加して黄色ペースト状の抽出物製剤7gを調製した。
(参照例3)
実施例2の抽出物10g及びクエン酸0.2gをエタノール89.8gに溶かした後、ろ過して淡黄色液状の抽出物製剤99gを調製した。
(比較例)
熟したマンゴスチンの果皮346gを70%エタノール1.1kg中で破砕して、70℃で5時間浸潰して抽出処理をした後、ろ紙でろ過した。ろ過液を減圧濃縮してエタノールを留去し、濃縮物を凍結乾燥して抽出物を赤色粉末として40.1gを回収した。
(試験例1)
実施例1及び比較例1で得た各抽出物0.01%液を高速液体クロマトグラフ装置(ODSカラム;検出波長:280nm)に注入して図1に示すクロマトグラムを得た。
実施例1のポリフェノール対応ピークは比較例に比べて大きく(特に保持時間12分及び16分付近のピーク)、ポリフェノール成分が多いことが示唆された。
(試験例2)
試料として実施例1・比較例1で得た各抽出物及びにカテキンをそれぞれ各200μgを含む10%メタノール溶液0.5mlを2.4%バニリンメタノール溶液3mlに加え、濃塩酸1.5mlを加えてよく混合後、20℃で15分間反応させた。これらの反応液の500nmにおける吸光度を測定した。
その結果は、表1に示すとおり実施例1の抽出物の吸光度は比較例の抽出物の約2.1倍、カテキンの約1.1倍のポリフェノール量を示し、試験例1の結果と同じであった。

Figure 2004007511
(試験例3)
試料として実施例1・比較例の各抽出物及びトコフェロールをそれぞれ各20μgを含む50%エタノール溶液2mlを0.1M酢酸緩衝液(pH5.5)2mlに添加した後、それぞれに0.2mM1,1−ジフェニル−2−ピクリルヒドラジル(DPPH)エタノール溶液1mlを加えた。30分後にこれらの反応液の517nmにおける吸光度を測定した。その結果、表2に示すとおりDPPHラジカルに基づく吸光度の減少(吸光度差)が実施例1では比較例の約2.0倍、トコフェロールの約1.7倍であった。
このことから、未熟果から抽出した本発明抽出物のDPPHラジカル消去作用(消去能)は完熟果から抽出した抽出物の約2.0倍高いことが分かった。
Figure 2004007511
(試験例4)
実施例1の抽出物、実施例4の非水溶性抽出物及び比較例の抽出物の枯草菌(Bacchillus sabtilis Marburg168)に対する抗菌活性を寒天希釈法により測定した結果、その最小発育阻止濃度は、それぞれ0.0075%、0.002%及び0.0075%であった。
なお、実施例1及び比較例は、水溶性と非水溶性の混合抽出物である。642 g of the extract (fruit crush; average thickness of about 2 mm) was crushed in 2.3 kg of extract (0.2% aqueous citric acid solution) and boiled for 20 min to perform the extraction process (extract / Solvent ≈ 1 / 3.6).
After cooling the extraction treatment liquid, the same operations as in Example 5 were performed, and the filter cloth extract was dried under reduced pressure to obtain 15.7 g of a water-insoluble extract (yellow powder) and a water-soluble extract (light brown powder). ) 79.6 g was collected (recovery rate for lottery ≈ 2.4% + 12.4%).
(Reference Example 1)
8 g of the water-soluble extract obtained in Example 1, 72 g of branched cyclodextrin (Nikken Chemical; Isoelite P) and 40 g of dextrin (Matsutani Chemical; Paindex 1) were dissolved in 400 ml of 50% ethanol and spray-dried. As an inclusion complex, 107 g of a light yellow powder extract preparation was prepared.
(Reference Example 2)
Dissolve 3 g of glycerin fatty acid ester (RIKEN vitamin; Poem M-100) in 20 ml of hot ethanol solution of 2 g of the water-insoluble extract obtained in Example 8, concentrate under reduced pressure, add 2 g of propylene glycol, and form a yellow paste 7 g of the extract formulation was prepared.
(Reference Example 3)
10 g of the extract of Example 2 and 0.2 g of citric acid were dissolved in 89.8 g of ethanol and then filtered to prepare 99 g of a pale yellow liquid extract preparation.
(Comparative example)
346 g of ripe mangosteen peel was crushed in 1.1 kg of 70% ethanol, soaked at 70 ° C. for 5 hours, extracted, and then filtered through filter paper. The filtrate was concentrated under reduced pressure to distill off ethanol, and the concentrate was lyophilized to recover 40.1 g of the extract as a red powder.
(Test Example 1)
Each extract 0.01% solution obtained in Example 1 and Comparative Example 1 was injected into a high performance liquid chromatograph (ODS column; detection wavelength: 280 nm) to obtain the chromatogram shown in FIG.
The peak corresponding to the polyphenol of Example 1 was larger than that of the comparative example (particularly, peaks at retention times of 12 minutes and 16 minutes), suggesting that the polyphenol component is large.
(Test Example 2)
As a sample, 0.5 ml of 10% methanol solution containing 200 μg each of each extract and catechin obtained in Example 1 and Comparative Example 1 was added to 3 ml of 2.4% vanillin methanol solution, and 1.5 ml of concentrated hydrochloric acid was added. After mixing well, the mixture was reacted at 20 ° C. for 15 minutes. The absorbance of these reaction solutions at 500 nm was measured.
As shown in Table 1, the absorbance of the extract of Example 1 was about 2.1 times that of the extract of Comparative Example and about 1.1 times that of catechin, which was the same as the result of Test Example 1. Met.
Figure 2004007511
(Test Example 3)
As a sample, 2 ml of a 50% ethanol solution containing 20 μg of each of the extracts of Example 1 and Comparative Example and tocopherol was added to 2 ml of 0.1 M acetate buffer (pH 5.5), and then 0.2 mM 1,1 each. -1 ml of diphenyl-2-picrylhydrazyl (DPPH) ethanol solution was added. After 30 minutes, the absorbance at 517 nm of these reaction solutions was measured. As a result, as shown in Table 2, the decrease in absorbance (absorbance difference) based on the DPPH radical was about 2.0 times that of the comparative example and about 1.7 times that of tocopherol.
From this, it was found that the DPPH radical scavenging action (scavenging ability) of the extract of the present invention extracted from immature fruits was about 2.0 times higher than that of the extract extracted from fully ripe fruits.
Figure 2004007511
(Test Example 4)
As a result of measuring the antibacterial activity of the extract of Example 1, the water-insoluble extract of Example 4 and the extract of Comparative Example against Bacillus subtilis Marburg 168 by the agar dilution method, the minimum inhibitory concentrations thereof were respectively 0.0075%, 0.002% and 0.0075%.
In addition, Example 1 and a comparative example are a water-soluble and water-insoluble mixed extract.

Claims (7)

未熟マンゴスチンの果実又は果皮を水及び/又は有機溶媒からなる抽剤で抽出した抽出物であることを特徴とするマンゴスチン抽出物。A mangosteen extract, which is an extract obtained by extracting a fruit or peel of immature mangosteen with an extractant comprising water and / or an organic solvent. 前記抽剤が、さらに褐変防止剤を含有するものであることを特徴とする請求項1記載のマンゴスチン抽出物。The mangosteen extract according to claim 1, wherein the extract further contains a browning inhibitor. 前記抽出物が水溶性であることを特徴とする請求項1又は2記載のマンゴスチン抽出物。The mangosteen extract according to claim 1 or 2, wherein the extract is water-soluble. 前記抽出物が非水溶性であることを特徴とする請求項1又は2記載のマンゴスチン抽出物。The mangosteen extract according to claim 1 or 2, wherein the extract is water-insoluble. 未熟なマンゴスチン果実を、褐変防止剤の存在下又は非存在下、水及び/又は有機溶媒に浸潰し、浸潰液をろ過後、ろ過液から溶媒を蒸発除去して濃縮ないし晶析操作を経て抽出物を回収することを特徴とするマンゴスチン抽出物の製造方法。The immature mangosteen fruit is crushed in water and / or an organic solvent in the presence or absence of an anti-browning agent, and after filtering the lysate, the solvent is removed from the filtrate by concentration or crystallization. A method for producing a mangosteen extract, comprising recovering the extract. 未熟なマンゴスチン果実を、褐変防止剤の存在下又は非存在下、水及び/又は有機溶媒に浸潰し、浸潰液をろ過後、ろ過液を濃縮して溶媒を留去することにより析出する黄色の非水溶性抽出物を、更にその除去液から溶媒を留去することにより水溶性抽出物を別々に得ることを特徴とするマンゴスチン抽出物の製造方法。Precipitated mangosteen fruit in the presence or absence of an anti-browning agent in water and / or organic solvent, filtered through the lysate, concentrated by distilling off the solvent after concentration of the filtrate A method for producing a mangosteen extract, characterized in that a water-soluble extract is obtained separately by further distilling off the solvent from the removal solution. 未熟なマンゴスチン果実を、褐変防止剤の存在下又は非存在下、水及び/又は有機溶媒に浸潰し、加温処理により析出する黄色物質を分取して非水溶性抽出物を、ろ過液から溶媒を留去することにより水溶性抽出物を別々に得ることを特徴とするマンゴスチン抽出物の製造方法。The immature mangosteen fruit is soaked in water and / or an organic solvent in the presence or absence of a browning inhibitor, and the yellow substance precipitated by heating treatment is separated to obtain a water-insoluble extract from the filtrate. A method for producing a mangosteen extract, wherein a water-soluble extract is obtained separately by distilling off the solvent.
JP2004521128A 2002-07-15 2003-06-02 Mangosteen extract Pending JPWO2004007511A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002205366 2002-07-15
JP2002205366 2002-07-15
PCT/JP2003/006936 WO2004007511A1 (en) 2002-07-15 2003-06-02 Mangostine extract

Publications (1)

Publication Number Publication Date
JPWO2004007511A1 true JPWO2004007511A1 (en) 2005-11-10

Family

ID=30112761

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004521128A Pending JPWO2004007511A1 (en) 2002-07-15 2003-06-02 Mangosteen extract

Country Status (2)

Country Link
JP (1) JPWO2004007511A1 (en)
WO (1) WO2004007511A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4571081B2 (en) * 2006-02-17 2010-10-27 株式会社アミノアップ化学 Lychee polyphenol-containing composition, production method and use thereof
CN103860439B (en) * 2014-04-09 2016-06-29 上海乐宝日化股份有限公司 A kind of whitening skin and preserving moisture skin care compositions and preparation method thereof
JP6607676B2 (en) * 2015-01-28 2019-11-20 花王株式会社 TRPV4 activator

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08225783A (en) * 1994-08-24 1996-09-03 Oda Mitsuo Natural antioxidant containing gamma-mangostin as active ingredient
JP2002330741A (en) * 2001-05-11 2002-11-19 Ogawa & Co Ltd Deterioration inhibitor for flavor or fragrance of food or cosmetic

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08225783A (en) * 1994-08-24 1996-09-03 Oda Mitsuo Natural antioxidant containing gamma-mangostin as active ingredient
JP2002330741A (en) * 2001-05-11 2002-11-19 Ogawa & Co Ltd Deterioration inhibitor for flavor or fragrance of food or cosmetic

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN6009059256, J Nat Prod, (April 2002) vol.65, p.761−763 *

Also Published As

Publication number Publication date
WO2004007511A1 (en) 2004-01-22

Similar Documents

Publication Publication Date Title
KR101485896B1 (en) Cosmetic composition for improving anti-oxidation, anti-inflammatory and atopic skin and method of preparing the same
JP4744447B2 (en) Gnetsum extract
JPH0222755B2 (en)
JPS59219384A (en) Preparation of natural antioxidant
JPH0978061A (en) Antioxidant
JP4730642B2 (en) Active oxygen scavenger and composition thereof
JP2004189698A (en) Bleaching agent, antioxidant, collagenase inhibitor, hyaluronidase inhibitor, age resister, skin lotion, cosmetic and food
JP5686328B2 (en) Anti-glycation composition
JP2015127339A (en) Composition for anti-saccharification
EP2250908B1 (en) Method for fermenting natural materials with salt and fermented extracts prepared therefrom
EP3042573B1 (en) Chlorogenic-acid-containing composition, method for manufacturing same, and drink or food item
EP1621194A1 (en) Active oxygen eliminator originating in natural material and use of the same
JPWO2004007511A1 (en) Mangosteen extract
JP2015025008A (en) Anti-glycation composition
JP2009143882A (en) Soya-cerebroside i derivative having tyrosinase-inhibiting activity
JP5399466B2 (en) Tyrosinase inhibitor
JP2001039822A (en) Esterase inhibitor
KR20050101217A (en) Compound, process for producing the same and use thereof
JP2013159603A (en) Method for producing anthocyanin derivative having skin-bleaching activity
JP6260804B2 (en) Anti-glycation composition
JP2012067061A (en) Maillard reaction inhibitor and aging improving agent
KR101612936B1 (en) The natural preservative manufacturing method of using Mandarin
JP6607418B2 (en) Anti-glycation composition
JP6447848B2 (en) Anti-glycation composition
KR101608882B1 (en) Cosmetic Composition Comprising Golden Peanut Extracts

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060529

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091117

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100316